Japan PhIII disappointment casts pall over Hisamitsu's terbinafine patch
This article was originally published in Scrip
Executive Summary
Japanese transdermal specialist Hisamitsu is weighing up its future development plans for a patch product for fungal nail infections following disappointing results from a Phase III trial.